Sherry Hsieh

Staff Reporter

Phone: 949-833-8373 Extension: 242

Recent Stories

Midday Stock Roundup

The S&P 500 was down 0.5% in midday trading to 2,873.96.

Tease photo

Glaucoma Competitor Exit Gives Ivantis, Glaukos Boost

HEALTHCARE: FDA OK for Hydrus Microstent

Irvine-based Ivantis Inc., an 11-year-old ophthalmic device maker of eyelash-sized stents used to treat glaucoma, couldn’t pick a better time to bring its first product, Hydrus Microstent, to market in the U.S.

Tease photo

Ex-DreamWorks Duo Launch VR Game

INNOVATION: VR firm gets local funding

“I wanted to take people to another world,” Spaces Inc. co-founder and Chief Executive Shiraz Akmal told the Business Journal at the preview event of its new Terminator VR experience: “Terminator Salvation: Fight for the Future.”

Evolus Evolution: More Sales, Marketing Hires on Tap

Latest Switch: Avelar Will Head R&D Team

Irvine-based Evolus Inc. (Nasdaq: EOLS), a medical aesthetics company that went public this year, continues to build out its management team under the direction of new Chief Executive David Moatazedi.

Concierge Key Names Afable New CEO

Newport Beach-based Concierge Key Health, which has created a mobile app for on-demand access to medical specialists, named Richard Afable as president and chief executive,

Tease photo

KPC Exec Moves Point To Integration and Buys

HEALTHCARE: Baronoff aims for more efficiency

Integration is task No. 1 for KPC Healthcare Inc.’s new chief executive, Peter Baronoff.

Tease photo

ChromaDex’s World Tour Hits New Zealand, Asia

Supplement Maker’s Next Stop Turkey

Irvine-based supplement maker ChromaDex Corp. (Nasdaq: CDXC) is ramping up international expansion efforts.

E-tailer Madaluxe Stores Fuels Sales

INNOVATION: CEO drives web traffic with new locales

Chief Executive Adam Freede describes MadaLuxe Group’s e-commerce platform for its direct-to-consumer division, MadaLuxe Vault, like “a startup division with a more established company.”

Ear, Nose, Throat Pharma Seeks Cash

HEALTHCARE: Plans to spend $20M for two trials

Novus Therapeutics Inc. (Nasdaq: NVUS) has its eyes—and ears—open for more funding.


Marwit Investment Management LLC has exited essentially all of its investments, giving Managing Partner Matthew Witte more time with family—including backing startups created by two of his kids.

Mission Hospital Rolls Out Three Midwifery Suites

Second in California With Hospital Birthing Center

There are basically two options for expecting mothers: obstetrician-gynecologists or midwives.

Former Proove CEO Meshkin Starts Venture Fund

HEALTHCARE: Plans lawsuits to fight ‘false allegations’

The most awful thing for Brian Meshkin was the Federal Bureau of Investigation raiding Proove Biosciences Inc.’s Irvine headquarters and making “political theater about it” with media on-site.

Rox Names CEO

San Clemente-based Rox Medical Inc. appointed Mike MacKinnon as chief executive. He came from Philips N.A. where he was head of sales for image guided technologies.

Tease photo

HCP REIT En Route To All-Private-Pay Portfolio

HEALTHCARE: Construction totals about $800 million

A third of the former “Big Three” senior housing real estate investment trusts is wearing a different color: HCP Inc. (NYSE: HCP) plans to slice its portfolio into three equal segments over the next few years.

Tease photo

Price Competition Results in Mixed Edwards Q2

HEALTHCARE: Says new valves should drive up Q4 sales

Recent stock reactions to Orange County’s largest publicly traded company speak to Edwards Lifesciences Corp.’s (NYSE: EW) second-quarter earnings.

Tease photo

Mynd Analytics Matches Seniors With Telehealth

Subsidiary Launches Behavioral Health Program

With the number of Americans 65 and older projected to outnumber children for the first time in U.S. history by 2030—census estimates show all baby boomers will be older than 65 then, expanding the size of the older population to 78 million—healthy aging is ever more important.

Biolase Gets New CEO

Irvine-based Biolase Inc. (Nasdaq: BIOL) on Aug. 8 named Todd Norbe president and chief executive.

Tease photo

Molecular Diagnostics Co. Agendia Raises $35M

HEALTHCARE: Commercial Expansion and Big Data Programs

The future of healthcare is moving towards precision, a.k.a., personalized medicine—and molecular diagnostics play an increasingly important role in one of the main components of precision medicine, gene-specific therapeutics.

Tease photo

Delta Dental Sees Steep Decline in OC Membership

Low-Cost Plan Not A Hit with Dentists

Net dental enrollment in dental HMO and PPO plans decreased more than 25% to about 2 million members in year through July.

Medical Pot Market Loosens

Operators Still Hope for More Open Fed

Policy changes and medical marijuana go hand in hand, and for Danielle Piomelli, professor of anatomy and neurobiology at University of California- Irvine, true progress is only possible if the federal status of the drug is changed.

Startups Leverage Devices to Prevent Illnesses

‘Really’ Wearables; Computer Best Practices

There’s no denying the healthcare of tomorrow won’t be limited to the four walls of a hospital and that technology will play a crucial role in enhancing the patient-centered model.

Oramed Shoots for Holy Grail of Diabetic Care

OC Trial Site Largest Of Nationwide Study

An oral form of insulin doesn’t exist yet, but Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) has announced it’s taking a major step toward attaining the Holy Grail of diabetes care.

HMO Members Up 4% in OC; PPO Numbers Flat

Providers Turn to Tech to Control Costs

To HMO or PPO, that’s the question. Orange County’s top health maintenance organizations experienced growth in the former and decline in the latter during the 12 months through July.

Patients Drive Adoption of ‘Alternative’ Medicine

Americans Forking Out Billions Out-of-Pocket

Healthcare is changing rapidly, pushed by the rise of a new breed of informed patient who is seeking alternatives to conventional treatments.

FDA Approval No Longer Device Makers’ Last Step

Design to ‘Real-World’ Trials; It’s a Value Play

Value-based care—the healthcare model designed to incentivize providers to improve patient recovery and reduce cost—is not news in California, an early adopter of the Affordable Care Act. The shift is also changing the approach to new-product adoption.

Masimo Strong Q2, Raises Guidance

Masimo Corp. (Nasdaq: MASI) reported revenue of $211.6 million, including royalty, with product revenue for the second quarter totaling $202 million, up 12.4% compared to the same quarter a year ago.

Tease photo

Quality Systems Revenue Up

Irvine-based Quality Systems Inc. (Nasdaq: QSII) reported $133.2 million in revenue for its latest quarterly results, a 1.7% year-over-year increase.

Tease photo


KPC Health System named Scott Rifkin as chief operating officer of KPC Healthcare.

Tease photo

Dental Players Glidewell, Smile Enter New Markets

DentalXChange Debuts Credential Platform

Smile Brands Inc. is making a foray into Nevada in a partnership with Las Vegas-based P3 Dental Group.

LensGen Gaze Fixed On Clinical Trial Start

HEALTHCARE: Funding release vote of confidence

Irvine-based LensGen Inc.’s recent $11 million funding, part of a $21 million Series A funding raised last May, represents a vote of confidence by investors.

Avid Starts Year as Contract Biologics Developer

HEALTHCARE: Appoints CFO, 3 others to leadership

Avid Bioservices Inc. (Nasdaq: CDMO) in Tustin reported fourth-quarter and fiscal-year results last week, marking year one of its remaking—a new name, business plan, management and board.

Tease photo

Urologic Therapeutic Co. Urovant Seeks $150M

HEALTHCARE: Three drug trials, overactive bladder first

Orange County’s adding a pharmaceutical company to its ecosystem that walks quietly and carries a big wallet.

Big Plans Ahead for Biopharma Company Urovant

Ex-Astellas Execs Join Now-5-Member Board

Clinical-stage biopharmaceutical company Urovant Sciences Ltd. appointed Sef Kurstjens and Pierre Legault to its board of directors, increasing the number of members from three to five (see related story on page 1).

Evolus Raises $56M

Evolus Inc. (Nasdaq: EOLS) priced an additional public offering of 4 million shares of common stock at $20 each. The offering consists of 3 million shares offered by the medical aesthetics company and a million shares offered by a selling stockholder.

Tease photo

Avid Names CFO

Avid Bioservices Inc. (Nasdaq: CDMO) appointed Daniel Hart chief financial officer.

Tease photo

Urovant Seeks $150M IPO

Irvine-based Urovant Sciences Inc. is seeking $150 million via the public markets to extend clinical trials of therapies to treat urologic conditions.

Tease photo

Aqua Medical Raises $4M in Series A Round

HEALTHCARE: Sees FDA nod by year-end

The digestive system measures up to 30 feet long in adults, including the esophagus, stomach, small intestine, large intestine, liver and pancreas.

Tease photo

Endologix Adds Quality to Firm’s Executive Team

Ex-Abbott Laboratories Jeffrey Fecho Joins Firm

Endologix Inc. (Nasdaq: ELGX) needs to nail down product quality.

Allergan CEO Saunders Says OC Operations Stay

Medicine at OCTANe Ophthalmology event

Orange County again proved it’s the center for ophthalmology. Heavy hitters like Aerie Pharmaceuticals Inc., Alcon, Johnson & Johnson Vision, Carl Zeiss Meditec Inc. and Allergan PLC shared their perspectives at OCTANe’s annual Ophthalmology Technology Summit on June 29 at Fashion Island Hotel.

Tease photo

De Novo Nod for Dialysis Device a 50-Year First

SJC Maker Avenu Said Its System Gives New Option

Don’t call it disruption.

Applied Cardiac Expands HQ with 24/7 Laboratory

Flagship Device Detects Heart Rhythm Disorders

ACS Diagnostics Inc. is moving into exciting, unchartered territory in ambulatory cardiac monitoring with its Food and Drug Administration-cleared CORE 12, which stands for cardiac outpatient real-time ECG.

Incubators BLD Capital, Adventus Launch in OC

STARTUPS: Hood kitchen doubles size, grows offerings

Innovation is the buzzword, but the entrepreneurial spirit isn’t limited to those with ideas for a company, but also unique incubation models.

Device Moves: Medtronic Gets FDA OK for MiniMed

Masimo Debuts Infrared Bluetooth Thermometer

The Food and Drug Administration approved the use of Medtronic PLC’s (NYSE: MDT) MiniMed 670G system in patients with Type 1 diabetes 7 years of age and older.

Soft Health Says Time to Say Goodbye to Bulky Pads

Female Incontinence Product Maker Seeks $3M

Incontinzence, or bladder leakage, is embarrassing, but not uncommon.

Allergan Reports Positive Data on Glaucoma Implant

Meanwhile, More Board Tweaks to Help Reposition

In light of impending generic competition, Allergan PLC recently made the point that its eye care business is more than dry-eye drug Restasis.

Bioskills Cadaver Labs Provider Axis Scales Business

HEALTHCARE: East Coast expansion will add 10,000 SF

Axis Research & Technologies is growing its footprint, starting with the July opening of a 10,000-square-foot facility in Columbia, Md.

Pyott Foundation Gives to Easterseals

The David and Molly Pyott Foundation gave a $1.7 million gift to Easterseals Southern California (ESSC).

Tease photo

Evolus Adds CMO

Evolus Inc. named Michael Jafar chief marketing officer, a new position, and its second recent hire from the executive ranks of Allergan plc.

Tease photo

Radical Changes Unlikely at Allergan

HEALTHCARE: Activists seek to unlock shareholder value

A letter from activist shareholders Appaloosa LP in Miami, Fla., and New York-based Senator Investment Group LP to Allergan PLC (NYSE: AGN) last week is a short-term blessing in disguise.

BioPhotas Woos Consumers With Hand-Held Device

‘Pod’ Priced to Move, Used For Multiple Conditions

The Orange County medical device scene continues to bustle with activity.